Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | $237.5M | $263.5M | $242.0M | $974.4M | $1,229.4M | $1,048.9M | $1,264.9M | $1,245.2M | $1,482.1M | $1,609.6M | $2,503.0M | $2,336.2M | $2,449.2M | $2,968.0M | $3,783.0M | $4,594.0M | $7,794.0M | $10.0B | $8,393.0M | $6,859.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Thermo Fisher Scientific Inc.'s last 12-month Operating Income is $7,332.0M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, Thermo Fisher Scientific Inc.'s Operating Income growth was 6.9%. The average annual Operating Income growth rates for Thermo Fisher Scientific Inc. have been (11.9%) over the past three years, 9.8% over the past five years.
Over the last year, Thermo Fisher Scientific Inc.'s Operating Income growth was 6.9%, which is higher than industry growth of (0.3%). It indicates that Thermo Fisher Scientific Inc.'s Operating Income growth is Good.